SGHT
Sight Sciences, Inc.
NASDAQ · USHealthcareMedical - Devices
$5.04+0.20%
Price as of Jul 20, 2026
SGHT profitability
Sight Sciences, Inc. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 86.2%
- EBITDA margin
- -39.8%
- EBIT margin
- -44.8%
- Net margin
- -46.8%
- Free cash flow margin
- -31.9%
Returns
- Return on equity
- -69.1%
- Return on assets
- -34.0%
- Return on invested capital
- -37.3%
- Asset turnover
- 0.71x
Cash efficiency
- Cash from operations
- -$25.1M
- Cash per share
- $1.56
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.